TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34475499

Group type: EXPERIMENTAL
Intervention: Genetically predicted IL-1Racp
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically predicted IL-1α
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL-1β, IL-1Ra, IL-36γ
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL-1α/β, IL-1Ra
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL-1β, IL-18BP
Number of subjects: 0
Study: 32362147

Group type: EXPERIMENTAL
Intervention: Emotion-focused (EM) writing group
Number of subjects: 71

Group type: COMPARATOR
Intervention: Fact-focused (FC) writing group
Number of subjects: 71
Study: 35410238

Group type: EXPERIMENTAL
Intervention: New ultrasound‐guided teaching group (acoustic shadowing‐facilitated ultrasound guidance)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Traditional ultrasound‐guided teaching group
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 116
Study: 33446126

Group type: EXPERIMENTAL
Intervention: In-home electronic medication dispensing system (MDS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Current methods of medication management (Control)
Number of subjects: 50
Study: 33154284

Group type: EXPERIMENTAL
Intervention: Oral nifedipine 20 mg every 30 min up to 5 doses
Number of subjects: 78

Group type: COMPARATOR
Intervention: Intravenous hydralazine 10 mg every 30 min up to 5 doses
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Oral nifedipine and intravenous hydralazine
Number of subjects: 78
Study: 35400298

Group type: EXPERIMENTAL
Intervention: Remote Ischemic Preconditioning (RIPC)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Local Ischemic Preconditioning (LIPC)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control
Number of subjects: 16
Study: 33615512

Group type: EXPERIMENTAL
Intervention: Intense pulsed light treatment on the forearm
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intense pulsed light treatment
Number of subjects: 10
Study: 32072587

Group type: EXPERIMENTAL
Intervention: Revised EMA Guideline on Strategies to Identify and Mitigate Risks for First‐in‐Human and Early Clinical Trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Case studies discussed during the DIAlogue Session
Number of subjects: 0
Study: 35450742

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg once daily
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg per day
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Combined solifenacin 5 mg and mirabegron 50 mg once daily
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 102
Study: 34544853

Group type: EXPERIMENTAL
Intervention: Task-specific motor therapy (20 extra hours) starting at ≤30 days after stroke (acute)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Task-specific motor therapy (20 extra hours) starting at 2 to 3 months after stroke (subacute)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Task-specific motor therapy (20 extra hours) starting at ≥6 months after stroke (chronic)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard motor rehabilitation (control group)
Number of subjects: 0
Study: 32746668

Group type: EXPERIMENTAL
Intervention: Dual-mobility (DM) cup
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Unipolar (UP) cup
Number of subjects: 1100
Study: 36162613

Group type: EXPERIMENTAL
Intervention: Bystander CPR
Number of subjects: 420671

Group type: COMPARATOR
Intervention: No bystander CPR
Number of subjects: 420671
Study: 33431304

Group type: EXPERIMENTAL
Intervention: Micro-dosed carbohydrate-electrolyte solution
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Carbohydrate-electrolyte trial
Number of subjects: 12
Study: 32350650

Group type: EXPERIMENTAL
Intervention: Consideration of prismatic side-effects of spectacle lenses and eye ball length in dosage planning (intervention group)
Number of subjects: 101

Group type: COMPARATOR
Intervention: No consideration of prismatic side-effects of spectacle lenses and eye ball length in dosage planning (control group)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Intervention group (esotropic patients)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Intervention group (patients with hyperopia > + 2 D)
Number of subjects: 101
Study: 35172056

Group type: EXPERIMENTAL
Intervention: EDP-938 600 mg once daily
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: EDP-938 300 mg twice daily after a 500 mg loading dose
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: EDP-938 300 mg once daily after a 600 mg loading dose
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: EDP-938 200 mg twice daily after a 400 mg loading dose
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: EDP-938 (all regimens)
Number of subjects: 178
Study: 34098518

Group type: EXPERIMENTAL
Intervention: Daridorexant (50 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daridorexant (50 mg) + Citalopram (20 mg at steady state)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Citalopram (20 mg, single dose and at steady state)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daridorexant (50 mg) + Citalopram (20 mg)
Number of subjects: 0
Study: 32921123

Group type: EXPERIMENTAL
Intervention: Tai chi exercises (24 simplified tai chi exercises)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Tai chi exercises
Number of subjects: 98

Group type: COMPARATOR
Intervention: Grip strength exercise (control group)
Number of subjects: 98
Study: 35747613

Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Inhibitory Kinesio taping
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 75
Study: 33832947

Group type: EXPERIMENTAL
Intervention: Post-nephrectomy KIM-1 levels
Number of subjects: 418
Study: 35898486

Group type: EXPERIMENTAL
Intervention: Daily finger gymnastics; exercise 2-3 times per day, ibuprofen sustained-release capsules if excessive pain occurs.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 60
Study: 32727157

Group type: EXPERIMENTAL
Intervention: Donkey Milk-Based Fortifiers (D-HMF)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Bovine Milk-Based Fortifiers (B-HMF)
Number of subjects: 54
Study: 36467884

Group type: EXPERIMENTAL
Intervention: Calibratable patient-specific instrumentation (PSI)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional operation (CO)
Number of subjects: 37
Study: 33332191

Group type: EXPERIMENTAL
Intervention: Intravesical maintenance Bacillus Calmette‐Guerin (mBCG)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Radical cystectomy (RC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Quality of life (QOL)
Number of subjects: 50
Study: 36273682

Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray plus a newly initiated oral antidepressant (ESK+AD)
Number of subjects: 560

Group type: COMPARATOR
Intervention: Placebo nasal spray plus oral antidepressant (AD+PBO)
Number of subjects: 560
Study: 33899195

Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI) recovery after exercise
Number of subjects: 20

Group type: COMPARATOR
Intervention: Passive recovery after exercise
Number of subjects: 20
Study: 32454841

Group type: EXPERIMENTAL
Intervention: Experimental group (story reading and nature exposure for 20 minutes each week for three weeks)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Waitlist control group (received intervention instructions three weeks later)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 200
Study: 35410736

Group type: EXPERIMENTAL
Intervention: Cartoon watching
Number of subjects: 56

Group type: COMPARATOR
Intervention: Bubble-blowing
Number of subjects: 56
Study: 33894690

Group type: EXPERIMENTAL
Intervention: FIFA11+kid (n = 28, 5 times per week)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (n = 27)
Number of subjects: 55
Study: 32747216

Group type: EXPERIMENTAL
Intervention: sIPV-bOPV-bOPV
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: sIPV-sIPV-bOPV
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: sIPV-sIPV-sIPV
Number of subjects: 648
Study: 34416778

Group type: EXPERIMENTAL
Intervention: Ibuprofen enema
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ibuprofen suppository
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both ibuprofen enema and suppository
Number of subjects: 0
Study: 33375952

Group type: EXPERIMENTAL
Intervention: Buprenorphine (BUP) 0.02 mg/kg IM
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sustained-release buprenorphine (BSR) 0.2 mg/kg SC
Number of subjects: 12
Study: 35747181

Group type: EXPERIMENTAL
Intervention: 2-dose measles vaccination (MV) at 4 and 9 months
Number of subjects: 6598

Group type: COMPARATOR
Intervention: 1-dose measles vaccination (MV) at 9 months
Number of subjects: 6598

Group type: EXPERIMENTAL
Intervention: 2-dose measles vaccination (MV) with no C-OPV
Number of subjects: 6598

Group type: EXPERIMENTAL
Intervention: 2-dose measles vaccination (MV) with C-OPV
Number of subjects: 6598

Group type: EXPERIMENTAL
Intervention: 2-dose measles vaccination (MV) at 4 months with maternal measles antibodies (MatAb)
Number of subjects: 6598
Study: 32966722

Group type: EXPERIMENTAL
Intervention: 5 mg zinc sulfate for 14 days
Number of subjects: 4500

Group type: EXPERIMENTAL
Intervention: 10 mg zinc sulfate for 14 days
Number of subjects: 4500

Group type: COMPARATOR
Intervention: 20 mg zinc sulfate for 14 days
Number of subjects: 4500
Study: 36097716

Group type: EXPERIMENTAL
Intervention: High controlling language
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High fear appeals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High disgust appeals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low controlling language, low fear, and low disgust appeals
Number of subjects: 0
Study: 34636974

Group type: EXPERIMENTAL
Intervention: Procalcitonin-guided antibiotic therapy (PCT group)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control group (antibiotic therapy managed at physician’s discretion)
Number of subjects: 159
Study: 36171048

Group type: EXPERIMENTAL
Intervention: Research questions formatted using the PICO structure submitted by stakeholders
Number of subjects: 0
Study: 32777945

Group type: EXPERIMENTAL
Intervention: Selenium intake (highest vs. lowest quartile)
Number of subjects: 991

Group type: EXPERIMENTAL
Intervention: Zinc intake (highest vs. lowest quartile)
Number of subjects: 991

Group type: EXPERIMENTAL
Intervention: Combined effect of zinc and SOD1 rs4998557
Number of subjects: 991
Study: 34108397

Group type: EXPERIMENTAL
Intervention: Genetically instrumented hearing loss
Number of subjects: 129731

Group type: EXPERIMENTAL
Intervention: Major depression
Number of subjects: 129731

Group type: EXPERIMENTAL
Intervention: Neuroticism
Number of subjects: 129731

Group type: EXPERIMENTAL
Intervention: Higher systolic blood pressure
Number of subjects: 129731

Group type: EXPERIMENTAL
Intervention: Longer duration in education
Number of subjects: 129731

Group type: EXPERIMENTAL
Intervention: Higher caffeine intake
Number of subjects: 129731

Group type: EXPERIMENTAL
Intervention: Being a morning person
Number of subjects: 129731

Group type: EXPERIMENTAL
Intervention: Higher genetic liability to neuroticism
Number of subjects: 129731

Group type: EXPERIMENTAL
Intervention: Higher genetic liability to schizophrenia
Number of subjects: 129731
Study: 33247395

Group type: EXPERIMENTAL
Intervention: Interactive distraction technique
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no interactive distraction)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Test group (interactive distraction)
Number of subjects: 48
Study: 32066726

Group type: EXPERIMENTAL
Intervention: Mindful Awareness Practice (MAP)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Health Education Program (HEP)
Number of subjects: 55
Study: 35086778

Group type: EXPERIMENTAL
Intervention: SCT (umbilical cord mesenchymal stromal cells plus autologous bone marrow mononuclear cells)
Number of subjects: 21
Study: 33482787

Group type: EXPERIMENTAL
Intervention: Park Prescription Intervention (PPI) including baseline counselling, exercise prescription in parks, materials, three-month follow-up counselling, and 26 weekly group exercise sessions in parks.
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Park PA at three months
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 160
Study: 32205521

Group type: EXPERIMENTAL
Intervention: Ideal OC2A and POCA postoperatively immediately after surgery and ambulation in BI group (26 patients).
Number of subjects: 150

Group type: COMPARATOR
Intervention: Ideal angle group in BI group.
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Ideal angle group in AAFD group (20 patients).
Number of subjects: 150

Group type: COMPARATOR
Intervention: Nonideal angle group in BI group.
Number of subjects: 150

Group type: COMPARATOR
Intervention: Nonideal angle group in AAFD group.
Number of subjects: 150
Study: 35847436

Group type: EXPERIMENTAL
Intervention: GM142 (newly developed gelatin film)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Conventional film (hyaluronate‐carboxymethylcellulose)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: GM142
Number of subjects: 146

Group type: COMPARATOR
Intervention: GM142 and Conventional film
Number of subjects: 146
Study: 34856936

Group type: EXPERIMENTAL
Intervention: Avelumab combined with cisplatin-gemcitabine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Avelumab combined with dose-dense methotrexate-vinblastine-doxorubicin-cisplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paclitaxel-gemcitabine associated with avelumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Avelumab alone
Number of subjects: 0
Study: 32970315

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination tablet containing 75-mg clopidogrel and 100-mg enteric ASA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Coadministration of one 75-mg clopidogrel tablet and one 100-mg enteric-coated ASA tablet
Number of subjects: 0
Study: 35135384

Group type: EXPERIMENTAL
Intervention: GEP‐DT (Gear exercise programme repeated at different times during the day): cycled for 90 seconds, repeated three times per day, three days per week.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GEP‐OT (Gear exercise programme repeated at one point in time): cycled for 90 seconds followed by four minutes and 30 seconds rest, repeated three times at one point in time, three days per week.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MICE (Moderate-intensity continuous exercise group): cycled for 30 minutes at 55-69% of HRmax.
Number of subjects: 0

Group type: COMPARATOR
Intervention: CTRL (Control group): did not exercise.
Number of subjects: 0
Study: 34163152

Group type: EXPERIMENTAL
Intervention: 40% FiO2 (group A)
Number of subjects: 662

Group type: COMPARATOR
Intervention: 80% FiO2 (group B)
Number of subjects: 662
Study: 32706883

Group type: EXPERIMENTAL
Intervention: Hormonal treatment (HT)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 35284778

Group type: EXPERIMENTAL
Intervention: Emicizumab 1.5 mg/kg once weekly (arm A)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Emicizumab 6 mg/kg every 4 weeks (arm B)
Number of subjects: 70

Group type: COMPARATOR
Intervention: No prophylaxis (arm C)
Number of subjects: 70
Study: 34678585

Group type: EXPERIMENTAL
Intervention: BCAA oral daily supplementation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo daily supplementation
Number of subjects: 60
Study: 35022839

Group type: EXPERIMENTAL
Intervention: Piezo-assisted turbinoplasty with bipolar coagulation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Partial turbinectomy with bipolar coagulation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Piezo-assisted turbinoplasty
Number of subjects: 100

Group type: COMPARATOR
Intervention: Partial turbinectomy
Number of subjects: 100
Study: 33023802

Group type: EXPERIMENTAL
Intervention: Curettage with cortical perforations
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard curettage (Control)
Number of subjects: 28
Study: 34482179

Group type: EXPERIMENTAL
Intervention: Tomuzotuximab (initial dose 990 mg then 720 mg) weekly with cisplatin 100 mg/m2 and fluorouracil (5-FU; 1000 mg/m2/day, days 1-4) every 3 weeks
Number of subjects: 240

Group type: COMPARATOR
Intervention: Cetuximab (400 mg/m2 subsequent 250 mg/m2) weekly with the same chemotherapeutic backbone
Number of subjects: 240
Study: 32277635

Group type: EXPERIMENTAL
Intervention: Laparoscopic complete mesocolic excision (CME)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Traditional radical operation
Number of subjects: 196
Study: 35970202

Group type: EXPERIMENTAL
Intervention: Umbilical cord milking
Number of subjects: 1780

Group type: COMPARATOR
Intervention: Early cord clamping
Number of subjects: 1780
Study: 34379119

Group type: EXPERIMENTAL
Intervention: PreLiFe-programme (mobile application with motivational interviewing every three months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention-control group
Number of subjects: 0
Study: 32672665

Group type: EXPERIMENTAL
Intervention: 9% SH-containing toothpaste (SHCT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3% SH-containing toothpaste (SHCT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0% SH-containing toothpaste (SHCT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 6% SH-containing toothpaste (SHCT)
Number of subjects: 40
Study: 36124513

Group type: EXPERIMENTAL
Intervention: Yoga with dietary modification
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Standard weight management
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 165
Study: 34493307

Group type: EXPERIMENTAL
Intervention: Tailored text messages (GHSH)
Number of subjects: 228

Group type: COMPARATOR
Intervention: No additional contact (control group)
Number of subjects: 228
Study: 32725875

Group type: EXPERIMENTAL
Intervention: Caphosol
Number of subjects: 56

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Caphosol and Saline
Number of subjects: 56
Study: 35438265

Group type: EXPERIMENTAL
Intervention: Direct composite restorations with a short fiber‐reinforced base (SFCRs)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Indirect glass‐ceramic endocrowns (GCEs)
Number of subjects: 18
Study: 33483897

Group type: EXPERIMENTAL
Intervention: Viral Combat (iPhone game)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 69
Study: 32280099

Group type: EXPERIMENTAL
Intervention: Clinical periodontal markers (Attachment Loss, probing pocket depth) and bacterial markers (pathogen immunoglobulin G)
Number of subjects: 0
Study: 35040416

Group type: EXPERIMENTAL
Intervention: Ultra-low-dose group (32 cases)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Low-dose group (32 cases)
Number of subjects: 64
Study: 33351886

Group type: EXPERIMENTAL
Intervention: Bonded retainer 13-23
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Bonded retainer 12-22
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Removable vacuum-formed retainer (VFR)
Number of subjects: 90
Study: 34047716

Group type: EXPERIMENTAL
Intervention: PEG with electrolyte (50 mL/kg) and oral bisacodyl (PEG+B group)
Number of subjects: 129

Group type: COMPARATOR
Intervention: PEG with electrolyte (70 mL/kg) and glycerol enema (PEG+G group)
Number of subjects: 129

Group type: COMPARATOR
Intervention: PEG+G group
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: PEG+B group
Number of subjects: 129
Study: 34481521

Group type: EXPERIMENTAL
Intervention: Over-the-head position
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Straddle position
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard position (control)
Number of subjects: 25
Study: 32341187

Group type: EXPERIMENTAL
Intervention: Daridorexant 10 mg
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Daridorexant 25 mg
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Daridorexant 50 mg
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 35960814

Group type: EXPERIMENTAL
Intervention: Combined Er:YAG laser and Nd:YAG laser treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 30
Study: 34366004

Group type: EXPERIMENTAL
Intervention: Complex interprofessional intervention including drug review by pharmacists, educational sessions for general practitioners and nurses, a drug safety toolbox, and change management seminars for 23 nursing homes with 452 residents.
Number of subjects: 862

Group type: COMPARATOR
Intervention: Usual care provided in 21 nursing homes with 410 residents.
Number of subjects: 862

Group type: EXPERIMENTAL
Intervention: Complex interprofessional intervention
Number of subjects: 862

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 862
Study: 34919884

Group type: EXPERIMENTAL
Intervention: 79.2 Gy of EBRT over 44 fractions
Number of subjects: 1532

Group type: COMPARATOR
Intervention: 70.2 Gy of EBRT over 39 fractions
Number of subjects: 1532
Study: 33545941

Group type: EXPERIMENTAL
Intervention: Herb-partitioned moxibustion plus lifestyle modification treatment
Number of subjects: 108

Group type: COMPARATOR
Intervention: Heat application group
Number of subjects: 108

Group type: COMPARATOR
Intervention: Medicated plaster group
Number of subjects: 108
Study: 35681155

Group type: EXPERIMENTAL
Intervention: Postpyloric tube feeding
Number of subjects: 924

Group type: COMPARATOR
Intervention: Gastric tube feeding
Number of subjects: 924
Study: 32129795

Group type: EXPERIMENTAL
Intervention: Patient self-report
Number of subjects: 8373

Group type: EXPERIMENTAL
Intervention: Pharmacy fill data
Number of subjects: 8373

Group type: EXPERIMENTAL
Intervention: Both patient self-report and pharmacy fill data
Number of subjects: 8373

Group type: EXPERIMENTAL
Intervention: Criterion standard definition
Number of subjects: 8373

Group type: EXPERIMENTAL
Intervention: Patients nonpersistent by both methods
Number of subjects: 8373
Study: 36203357

Group type: EXPERIMENTAL
Intervention: Site 1 (hand wrist)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Site 2 (distal quarter of the forearm)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Site 3 (midpoint of the forearm)
Number of subjects: 94